<DOC>
	<DOCNO>NCT00344175</DOCNO>
	<brief_summary>This sixteen-week follow-on 28 week single-blind extension study patient participate study NK-104-304 .</brief_summary>
	<brief_title>Follow-on Protocol Pitavastatin Versus Simvastatin Patients With Hypercholesterolemia Dyslipidemia Coronary Heart Disease Risk Factors</brief_title>
	<detailed_description>This sixteen-week , double-blind , active control , follow-on 28 week single blind extension study patient participate NK-104-304 .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Pitavastatin</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Completed NK104304 ( NCT 00309738 ) Hypercholesterolemia combine dyslipidemia 2 risk factor coronary heart disease ( CHD ) Withdrawn terminate NK104304 ( 00309738 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>hypercholesterolemia</keyword>
	<keyword>dyslipidemia</keyword>
	<keyword>CHD</keyword>
	<keyword>pitavastatin</keyword>
	<keyword>simvastatin</keyword>
	<keyword>2 risk factor coronary heart disease</keyword>
	<keyword>combine dyslipidemia</keyword>
</DOC>